The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Welcome,         Profile    Billing    Logout  
 6 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Keller, Michael
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
NCT03878069: Registry Study of Revcovi Treatment in Patients With ADA-SCID

Completed
N/A
32
US
elapegademase-lvlr, Revcovi
Chiesi Farmaceutici S.p.A.
Adenosine Deaminase Severe Combined Immunodeficiency
01/23
01/23
NCT04861714: Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)

Active, not recruiting
N/A
75
US
Regeneten, Standard repair
Ohio State University, Smith & Nephew, Inc.
Arthroplasty, Replacement, Shoulder
12/24
04/25
Jain, Tania
SENTRY, NCT04562389: Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis

Checkmark Presentation of data from Phase 1 trial for 1L Myelofibrosis at ASH 2022
Dec 2022 - Dec 2022: Presentation of data from Phase 1 trial for 1L Myelofibrosis at ASH 2022
Hourglass Dec 2022 - Dec 2022 : Data from trial in combination with ruxolitinib myelofibrosis
Checkmark Data from trial in combination with ruxolitinib myelofibrosis at ASH 2022
Dec 2022 - Dec 2022: Data from trial in combination with ruxolitinib myelofibrosis at ASH 2022
More
Recruiting
3
350
Europe, Canada, US, RoW
Selinexor, KPT-330, Placebo, Ruxolitinib
Karyopharm Therapeutics Inc
Myelofibrosis
09/25
03/28
ALLOHA, NCT05473910: A Study of TSC-100 and TSC-101 in AML, ALL and MDS Patients Undergoing Haploidentical Donor Transplantation

Recruiting
1
63
US
SOC + TSC-100, SOC + TSC-101, Control
TScan Therapeutics, Inc.
AML, Myelodysplastic Syndromes, ALL, Adult
12/25
06/26

Download Options